Concepedia

Publication | Open Access

Metformin restores crizotinib sensitivity in crizotinib-resistant human lung cancer cells through inhibition of IGF1-R signaling pathway

DOIFull Paper Access

45

Citations

25

References

2016

Year

Li Li, Yubo Wang, Tao Peng, Kejun Zhang, Caiyu Lin, Rui Han, Conghua Lu, Yong He
Oncotarget

Abstract

Metformin may be used in combination with crizotinib in ALK+ NSCLC patients to overcome crizotinib resistance and prolong survival.

References

YearCitations

Page 1